Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) COO Ryan Fukushima sold 17,460 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $1,303,389.00. Following the completion of the sale, the chief operating officer owned 839,180 shares in the company, valued at approximately $62,644,787. The trade was a 2.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Ryan Fukushima also recently made the following trade(s):
- On Monday, July 7th, Ryan Fukushima sold 5,000 shares of Tempus AI stock. The shares were sold at an average price of $60.00, for a total value of $300,000.00.
Tempus AI Stock Up 4.7%
Shares of NASDAQ TEM traded up $3.43 during mid-day trading on Thursday, hitting $76.71. The company had a trading volume of 15,579,085 shares, compared to its average volume of 12,600,730. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. The company has a market capitalization of $13.33 billion, a PE ratio of -64.46 and a beta of 4.98. The business's 50-day simple moving average is $63.48 and its 200 day simple moving average is $58.98.
Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company had revenue of $314.64 million for the quarter, compared to analysts' expectations of $296.84 million. During the same period last year, the firm earned ($6.86) earnings per share. Tempus AI's quarterly revenue was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. On average, analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on TEM. Bank of America raised their price target on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Needham & Company LLC restated a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a research note on Friday, August 8th. Guggenheim lifted their target price on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. BTIG Research lifted their target price on Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research report on Wednesday. Finally, Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a research report on Friday, August 8th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $67.64.
Check Out Our Latest Stock Report on Tempus AI
Hedge Funds Weigh In On Tempus AI
Institutional investors have recently added to or reduced their stakes in the stock. Pathway Capital Management LP acquired a new position in Tempus AI in the 1st quarter valued at about $8,576,000. Wells Fargo & Company MN increased its position in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after acquiring an additional 278 shares during the period. SeaCrest Wealth Management LLC acquired a new position in Tempus AI in the 1st quarter valued at about $535,000. Sumitomo Mitsui Trust Group Inc. increased its position in Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after acquiring an additional 1,016,384 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its position in Tempus AI by 92.6% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company's stock valued at $27,926,000 after acquiring an additional 278,311 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.